| CSH guidelines for the diagnosis and treatment of drug-induced liver injury Y Yu, Y Mao, C Chen, J Chen, J Chen, W Cong, Y Ding, Z Duan, Q Fu, ... Hepatology international 11, 221-241, 2017 | 322 | 2017 |
| Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury R Lai, X Xiang, R Mo, R Bao, P Wang, S Guo, G Zhao, H Gui, H Wang, ... Journal of hepatology 63 (1), 148-155, 2015 | 71 | 2015 |
| Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury R Mo, R Lai, J Lu, Y Zhuang, T Zhou, S Jiang, P Ren, Z Li, Z Cao, Y Liu, ... Theranostics 8 (15), 4170, 2018 | 57 | 2018 |
| miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate hepatic glycolipid metabolism disorder L Fan, R Lai, N Ma, Y Dong, Y Li, Q Wu, J Qiao, H Lu, L Gong, Z Tao, ... Journal of hepatology 74 (1), 8-19, 2021 | 50 | 2021 |
| Drug-induced Liver Injury (DILI) Study Group YC Yu, YM Mao, CW Chen, JJ Chen, J Chen, WM Cong, Y Ding, ZP Duan, ... Chinese Society of Hepatology (CSH). Chinese Medical Association (CMA). CSH …, 2017 | 31 | 2017 |
| Persistently elevated circulating Th22 reversely correlates with prognosis in HBV‐related acute‐on‐chronic liver failure R Mo, P Wang, R Lai, F Li, Y Liu, S Jiang, G Zhao, S Guo, H Zhou, L Lin, ... Journal of Gastroenterology and hepatology 32 (3), 677-686, 2017 | 30 | 2017 |
| Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma P Wang, R Mo, R Lai, Y Xu, J Lu, G Zhao, Y Liu, Z Cao, X Wang, Z Li, ... Oncotarget 8 (62), 105407, 2017 | 23 | 2017 |
| 138 例药物性肝损伤患者的临床特征及肝脏组织学改变 赖荣陶， 王晖， 桂红莲， 叶敏贞， 戴维佳， 项晓刚， 赵钢德， 王伟静， 谢青 中华肝脏病杂志 20 (3), 185-189, 2012 | 23 | 2012 |
| Fibroscan 在慢性乙型肝炎肝纤维化诊断中的作用及影响因素 刘柯慧， 吴海清， 阮隽， 赖荣陶， 桂红莲， 周惠娟， 余敏杰， 林兰意， 谢青， ... 肝脏 17 (9), 621-625, 2012 | 20 | 2012 |
| Correlation between circulating miR‐122 and prognosis of chronic HBV‐related liver failure WJ Wang, RT Lai, J Lu, XG Xiang, GD Zhao, WL Tang, W Cai, H Wang, ... Journal of digestive diseases 17 (5), 334-339, 2016 | 18 | 2016 |
| SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver disease Y Liu, F Yu, Y Han, Q Li, Z Cao, X Xiang, S Jiang, X Wang, J Lu, R Lai, ... Scientific reports 6 (1), 37351, 2016 | 17 | 2016 |
| Application of fatty liver inhibition of progression algorithm and steatosis, activity, and fibrosis score to assess the impact of non-alcoholic fatty liver on untreated … Y Huang, Q Gan, R Lai, W Wang, S Guo, Z Sheng, L Chen, Q Guo, W Cai, ... Frontiers in Cellular and Infection Microbiology 11, 733348, 2022 | 16 | 2022 |
| 231 例药物性肝损伤临床分析 王晓今， 陈成伟， 刘光华， 傅青春， 倪鎏达， 赖荣陶， 齐慧慧， 陈姝 肝脏 12 (5), 363-365, 2007 | 16 | 2007 |
| Long non-coding RNA NEAT1 alleviates acute-on-chronic liver failure through blocking TRAF6 mediated inflammatory response Y Xu, Z Cao, Y Ding, Z Li, X Xiang, R Lai, Z Sheng, Y Liu, W Cai, R Hu, ... Frontiers in Physiology 10, 1503, 2019 | 15 | 2019 |
| Bicyclol for the treatment of drug-induced liver injury: a propensity score matching analysis using a nationwide inpatient database Y Wang, R Lai, P Zong, Q Xu, J Shang, X Zhang, W Zhong, J Tang, X Han, ... Journal of International Medical Research 49 (4), 03000605211005945, 2021 | 13 | 2021 |
| 113 例药物性肝损害临床特征及影响因素分析 戴维佳， 赖荣陶， 王晖， 谢青， 汤伟亮， 庄焱， 桂红莲， 余敏杰， 谢敬东， ... 临床肝胆病杂志 27 (10), 1058-1061+ 1065, 2011 | 13 | 2011 |
| 抗结核药物所致肝损伤 赖荣陶， 陈成伟 中华肝脏病杂志 19 (8), 634-636, 2011 | 10 | 2011 |
| 对乙酰氨基酚所致肝损伤的临床诊治新进展 赖荣陶， 谢青 肝脏 16 (2), 159-161, 2011 | 9 | 2011 |
| Laboratory-based surveillance and clinical profile of sporadic HEV infection in Shanghai, China J Lu, Q Li, J Jiang, Z Li, P Wang, Z Sheng, R Lai, H Zhou, W Cai, H Wang, ... Virologica Sinica, 1-11, 2021 | 7 | 2021 |
| Sentinel surveillance strategies for early detection of coronavirus disease in fever clinics: experience from China R Lai, E Chen, W Gao, C Cheng, Q Xie Epidemiology & Infection 148, e205, 2020 | 7 | 2020 |